Cristin Rothfuss serves as Executive at Sarepta Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cristin Rothfuss has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 28, 2025 involved selling 229 shares valued at $4.8K.
Cristin Rothfuss currently holds 139,756 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cristin Rothfuss has been a net neutral trader of SRPT stock. They have purchased $0 and sold $0 worth of shares.
Cristin Rothfuss's most recent insider trade was on Nov 28, 2025, when they sold 229 shares at $21.12 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 3, 2025 | SRPT | $0 | Award | 25,000 | $N/A | Discretionary |